Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Cognitive Change

Haukeland University HospitalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Cognitive Change cohort.

Asset / SponsorPhaseRating
Namenda
UNC Lineberger Comprehensive Cancer Center
Phase 4BB
DESVENLAFAXINE
David Steffens
Phase 4BB
Wellbutrin
David Steffens
Phase 4BB
Sertraline
David Steffens
Phase 4BB
Vortioxetine
Brain and Cognition Discovery Foundation
Phase 2/3B

View all 10 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →